Paul J. Sekhri - 17 Feb 2026 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship
Pres, CEO and Exec Chairperson, Director
Issuer ticker
VTVT
Reported as of
17 Feb 2026
Net transaction value
+$5,168,800
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2026, 16:10:32 UTC
Prior SEC filing
03 Dec 2025
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul J. Sekhri

Key filing fact

Paul J. Sekhri filed Form 4 for vTv Therapeutics Inc. (VTVT) on 18 Feb 2026.

Key facts

  • This page summarizes Paul J. Sekhri's Form 4 filing for vTv Therapeutics Inc. (VTVT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Feb 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 03 Dec 2025.
  • Current net transaction value: +$5,168,800.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001264519 Primary reporting owner

SEKHRI PAUL J

Relationship
Pres, CEO and Exec Chairperson, Director
Address
C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT
Signature
/s/ Paul J. Sekhri
Signature date
18 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Class A Common Stock

Award

Transaction value
$5,168,800
Shares
+140,000
Change %
+56%
Price
$36.92
Shares after
392,212
Date
17 Feb 2026
Ownership
Direct
Underlying class
Class A Common Stock ("Common Stock")
Underlying amount
140,000
Exercise price
$36.92
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .